Microbial-isolate identification and testing IVDs

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Commercializzato da:

Biomerieux Australia Pty Ltd

Classe:

Class 2

Prodotto da:

bioMerieux Inc 100 Rodolphe Street, Durham, NC, 27712 United States Of America

Area terapeutica:

CT1261 - Microbial-isolate identification and testing IVDs

Indicazioni terapeutiche:

IVDs intended to be used in testing to provide information about the specific in vitro characteristics and/or identification of microorganisms including bacteria, yeast, fungi, viruses and parasites that have been isolated from a clinical specimen.

Stato dell'autorizzazione:

A

Data dell'autorizzazione:

2013-09-26